Results of a surveillance programme for patients at high risk of malignant melanoma using digital and conventional dermoscopy

European Journal of Cancer Prevention

Volumn 13, Issue 2, 2004, Pages 133-138

  Haenssle, H A ^a   Vente, C ^a   Bertsch, H P ^a   Rupprecht, R ^a   Abuzahra, F ^a   Junghans, V ^a   Ellinghaus, B ^a   Emmert, S ^a   Hallermann, C ^a   Rosenberger, A ^a   Neumann, C ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Atypical mole syndrome; Cutaneous melanoma; Digital epiluminescence microscopy; Dysplastic naevus; Epiluminescence microscopy; Follow up study

Indexed keywords

ADULT; ALGORITHM; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RISK; CANCER SCREENING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOCUMENTATION; EPILUMINESCENCE MICROSCOPY; FAMILY HISTORY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; NEVUS; OBSERVATION; PHENOTYPE; PHOTOGRAPHY; PIGMENTATION; PRIORITY JOURNAL; SKIN CANCER;

EID: 2342571124     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-200404000-00007     Document Type: Article

References (33)

1. Argenziano G, Fabbrocini G, Carli P, De Giorgi V, Delfino M (1997). Epiluminescence microscopy: criteria of cutaneous melanoma progression. J Am Acad Dermatol 37: 68-74.
2. Ascierto PA, Palmieri G, Celentano E, et al. (2000). Sensitivity and specificity of epiluminescence microscopy, evaluation on a sample of 2731 excised cutaneous pigmented lesions. The melanoma cooperative study. Br J Dermatol 142: 893-898.
3. Bahmer FA, Fritsch P, Kreusch J, et al. (1990). Terminology in surface microscopy. Consensus meeting of the Committee on Analytical Morphology of the Arbeitsgemeinschaft Dermatologische Forschung, Hamburg, Federal Republic of Germany 17 November 1989. J Am Acad Dermatol 23: 1159-1162.
4. Bataille V (2000). Genetics of familial and sporadic melanoma. Clin Exp Dermatol 25: 464-470.
5. Binder M, Kittler H, Seeber A, et al. (1998). Epiluminescence microscopy-based classification of pigmented skin lesions using computerized image analysis and an artificial neural network. Melanoma Res 8: 261-266.
6. Bishop JA, Wachsmuth RC, Harland M, et al. (2000). Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations. J Invest Dermatol 114: 28-33.
7. Braun RP, Lemonnier E, Guillod J, et al. (1998). Two types of pattern modification detected on the follow-up of benign melanocytic skin lesions by digitized epiluminescence microscopy. Melanoma Res 8: 431-437.
8. Clark WH Jr, Elder DE, Guerry D, et al. (1984). A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol 15: 1147-1165.
9. Garbe C, Buttner P, Weiss J et al. (1994). Associated factors in the prevalence of more than 50 common melanocytic nevi, atypical melanocytic nevi, and actinic lentigines: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol 102: 700-707.
10. Greene MH (1999). The genetics of hereditary melanoma and nevi; 1998 update. Cancer 86: 2464-2477.
11. Holly EA, Kelly JW, Shpall SN, Chiu SH (1987). Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 17: 459-468.
12. Holman CD, Armstrong BK, Heenan PJ, et al. (1986). The causes of malignant melanoma: results from the West Australian Lions Melanoma Research Project. Recent Results Cancer Res 102: 18-37.
13. Kelly JW, Yeatman JM, Regalia C, Mason G, Henham AP (1997). A high incidence of melanoma found in patienta with multiple dysplastic naevi by photographic surveillance. Med J Aust 167: 191-194.
14. Kenet RO, Kang S, Kenet BJ, et al. (1993). Clinical diagnosis of pigmented lesions using digital epiluminescence microscopy. Grading protocol and atlas. Arch Dermatol 129: 157-174.
15. Kittler H, Binder M (2001). Risks and benefits of sequential imaging of melanocytic skin lesions in patients with multiple atypical nevi. Arch Dermatol 137: 1590-1595.
16. Kittler H, Pehamberger H, Wolff K, Binder M (2000). Follow-up of melanocytic skin lesions with digital epiluminescence microscopy: patterns of modifications observed in early melanoma, atypical nevi, and common nevi. J Am Acad Dermatol 43: 467-476.
17. Koh HK, Geller AC, Miller DR, Grossbart TA, Lew RA (1996). Prevention and early detection strategies for melanoma and skin cancer. Current status. Arch Dermatol 132: 436-443.
18. Kölmel KF (1996). Prävention des malignen melanoma der haut. Onkologe 2: 428-440.
19. MacKie RM, Freudenberger T, Aitchison TC (1989). Personal risk-factor chart for cutaneous melanoma. Lancet 2: 487-490.
20. Masri GD, Clark WH Jr, Guerry D, Halpem A, Thompson CJ, Elder DE (1990). Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease. J Am Acad Dermatol 22: 1042-1048.
21. Menzies SW, Gutenev A, Avramidis M, Batrac A, McCarthy WH (2001). Short-term digital surface microscopic monitoring of atypical or changing melanocytic lesions. Arch Dermatol 137: 1583-1589.
22. Pehamberger H, Steiner A, Wolff K (1967). In vivo epiluminescence microscopy of pigmented skin lesions. I. Pattern analysis of pigmented skin lesions. J Am Acad Dermatol 17: 571-583.
23. Pehamberger H, Binder M, Steiner A, Wolff K (1993). In vivo epiluminescence microscopy: improvement of early diagnosis of melanoma. J Invest Dermatol 100: 356S-362S.
24. Rigel DS, Rivers JK, Kopf AW, et al. (1989). Dysplastic nevi markers for increased risk for melanoma. Cancer 63: 386-389.
25. Sagebiel RW (1989). The dysplastic melanocytic nevus. J Am Acad Dermatol 20: 496-501.
26. Slue W, Kopf AW, Rivers JK (1966). Total-body photographs of dysplastic nevi. Arch Dermatol 124: 1239-1243.
27. Snels DG, Hille ET, Gruis NA, Bergman W (1999). Risk of cutaneous malignant melanoma in patients with nonfamilial atypical nevi from a pigmented lesions clinic. J Am Acad Dermatol 40: 686-693.
28. Stam-Posthuma JJ, van Duinen C, Scheffer E, Vink J, Bergman W (2001). Multiple primary melanomas. J Am Acad Dermatol 44: 22-27.
29. Stanganelli I, Bauer P, Bucchi L, et al. (1997). Critical effects of intense sun exposure on the expression of epiluminescence microscopy features of acquired melanocytic nevi. Arch Dermatol 133: 979-982.
30. Stanganelli I, Serafini M, Bucch L (2000). A cancer-registry-assisted evaluation of the accuracy of digital epiluminescence microscopy associated with clinical examination of pigmented skin lesions. Dermatology 200: 11-16.
31. Stolz W, Schiffner R, Pillet L, et al. (1996). Improvement of monitoring of melanocytic skin lesions with the use of a computerized acquisition and surveillance unit with a skin surface microscopic television camera. J Am Acad Dermatol 35: 202-207.
32. Tucker MA, Halpem A, Holly EA, et al. (1997). Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma. JAMA 277: 1439-1444.
33. Yadav S, Vossaert KA, Kopf AW, Silverman M, Grin-Jorgensen C (1993). Histopathologic correlates of structures seen on dermoscopy (epiluminescence microscopy). Am J Dermatopathol 15: 297-305.